Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1990-09-10
1993-08-03
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514562, 514381, 514538, 514539, 562442, 562426, 562443, 562451, 560 42, 560 37, 548253, 548251, A61K 3119, C07C22934
Patent
active
052329488
ABSTRACT:
Monocyclic aryl compounds having selective LTB.sub.4 antagonists properties and comprising an amido substituent, a substituent group having a terminal carboxylic acid or derivative thereof and a lipophilic substituent, therapeutic compositions and methods of treatment of disorders which result from LTB.sub.4 activity using the monocyclic aryl compounds are disclosed.
REFERENCES:
patent: 3828095 (1974-08-01), Boschetti
patent: 4460580 (1984-07-01), Ostermayer et al.
patent: 4497813 (1985-02-01), Ostermayer et al.
F. Ostermayer et al. (IV), Chemical Abstracts 93:P220465r, p. 502, (1980) English abstract of E.P. patent 5,848.
F. Ostermayer et al. (III), Chemical Abstracts 94:121135x, p. 660 (1981) English abstract of E.P. patent 15,505.
Chan Wan K.
Chang Michael N.
Galemmo, Jr. Robert A.
Huang Fu-chih
Sutherland Charles A.
Nicholson James A.
Raymond Richard L.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Russell Mark W.
Savitzky Marin F.
LandOfFree
Substituted monocyclic aryl compounds exhibiting selective leuko does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted monocyclic aryl compounds exhibiting selective leuko, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted monocyclic aryl compounds exhibiting selective leuko will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2270610